Amgen To Webcast Investor Call At ASH 2017

THOUSAND OAKS, Calif., Dec. 6, 2017 /PRNewswire/ -- Amgen (NASDAQ:AMGN) will host a webcast call for the investment community at the 59th American Society of Hematology (ASH) Annual Meeting & Exposition on Saturday, Dec. 9, 2017, at 11:30 a.m. ET. David M. Reese, M.D., senior vice president of Translational Sciences and Oncology at Amgen, together with other members of Amgen's management team and a clinical investigator, will participate to discuss the Company's oncology program, including our BiTE® immunotherapy platform. Live audio of the investor call will be simultaneously broadcast over the Internet and will be available to members of the news media, investors and the general pub...
Source: Amgen News Release - Category: Pharmaceuticals Tags: Uncategorized Source Type: news